Risk Prediction Model for Severe Autoimmune Encephalitis

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

December 31, 2028

Conditions
Severe Autoimmune Encephalitis
Interventions
OTHER

No Intervention: Observational Cohort

No intervention

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06697678 - Risk Prediction Model for Severe Autoimmune Encephalitis | Biotech Hunter | Biotech Hunter